I've had the first two injections of the HepB vaccine and was told I needed to have the third 6 months after the first which would have been Oct. 1. I missed it. How long to I have to get the third vaccine and still be protected? Do I still have time to do it or do I need to start the...
ROTATEQ(R) (Rotavirus Vaccine, Live, Oral, Pentavalent), Merck's vaccine for rotavirus gastroenteritis in infants and children, received the Prix Galien USA 2010 Award for Best Biotechnology Product, Merck announced last week. "We are honored that Merck's long-term commitment to the discovery...
Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced that Inovio Pharmaceuticals and the University of Pennsylvania have received a grant of $3.1 million from the National Institutes...
The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) awarded a $51 million contract to Emergent BioSolutions, Inc., of Rockville, Md., for the development of a new anthrax vaccine using the protective antigen (rPA) to stimulate a...
Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced the Phase I clinical study assessing Inovio's PENNVAX™-B DNA vaccine delivered using its proprietary electroporation technology in...
New data presented by Novartis Vaccines involving thousands of babies indicates that an investigational vaccine has the potential to be the first broad-coverage vaccine against the deadly meningococcal B (meningitis B) disease. 1 There is currently no broad-protection vaccine available...
Recognizing the important role vaccination of health care workers plays in a comprehensive seasonal influenza prevention plan, the American Nurses Association (ANA) continues to urge all registered nurses to get vaccinated every year to protect themselves, their families, and the patients they...
The WHO "has granted prequalification status to Pfizer Inc.'s children's pneumococcal vaccine, Prevenar 13, paving the way for United Nations agencies and governments to start ordering the product," the Associated Press reports (8/23). The WHO decision comes after Pfizer in March entered...
New Meningitis Vaccine Scheduled For 'Mass Campaign' In October The WHO "recently gave approval to a new meningitis vaccine that is expected to cost only 50 cents a dose, a price many African governments and donors can afford," the New York Times reports. The vaccine is produced by the...
Switzerland's Cytos Biotechnology and Singapore's Agency for Science, Technology and Research (A*STAR) have jointly announced their first collaboration on a virus-like particle (VLP) vaccine. This partnership, which involves academic and clinical partners across Singapore, aims at research...
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, is mentioned in two recent articles covering a historic HIV vaccine trial currently being conducted by the AIDS Research Consortium of Atlanta (ARCA) using a...
The International AIDS Vaccine Initiative (IAVI) announced that the Government of Japan pledged a US$10 million grant to support AIDS vaccine research and development over the next five years. The grant, which will be channeled through a newly established World Bank trust fund, is the first of...
The British Veterinary Association (BVA) welcomes the Government's intention to reassess its TB strategy promising to look at both vaccine and culling options as part of a science led policy of badger control in TB prevalent areas. However the BVA has some concerns that Defra's announcement to...
There is no malaria vaccine available today. Malaria sickens almost a quarter of a billion people each year and kills a child every 30 seconds. That could be changing: researchers at The Rockefeller University have genetically transformed the yellow fever vaccine to prime the immune system to...
GlaxoSmithKline (NYSE: GSK) announced that the Food and Drug Administration (FDA) has determined that U.S. healthcare practitioners can resume the use of Rotarix® (Rotavirus Vaccine, Live, Oral), effective immediately. This action supersedes the FDA's recommendation from March 22, 2010 and...
Advances in vaccine delivery and efficacy were discussed at the 44th National Immunization Conference sponsored by the Centers for Disease Control and Prevention (CDC). A research study by each of the four directors from the Center for Vaccine Awareness and Research at Texas Children's Hospital...
Some of the human immune system's defences against the virus that causes dengue fever actually help the virus to infect more cells, according to new research published in the journal Science. The researchers behind the work, from Imperial College London, hope their new findings could help with...
Men 45 years or older who received pneumococcal vaccine were not less likely to have a heart attack or stroke compared to men who did not receive the vaccine, according to a study in the May 5 issue of JAMA. Hung Fu Tseng, Ph.D...
More...
Mystic Pharmaceuticals today announced it has been granted U.S. Patent 7,669,597, a key technology of its VRx2™ drug delivery platform. The VRx2™ Delivery Platform provides preservative free, precision dose delivery for ophthalmic and intranasal drugs and biologics. The issued patent covers...
AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the...